The authors applied in vitro models of controlled damage to human epidermal keratinocytes (HEKs), human skin fibroblasts (HSFs), and human breast skin tissue (HBST) to examine the mechanism responsible for sulfur mustard (HD)-induced interleukin-6 (IL-6) alterations. Treatment with 100 μM HD for 24 hours resulted in a significant increased amount of IL-6 being secreted by HEKs (HD-exposed to control ratio [E/C] = 4.15 ± 0.07) and by HSFs (E/C = 7.66 ± 0.04). Furthermore, the HD-induced secretion of IL-6 in HEKs was neutralized with monoclonal human IL-6 antibodies. The secretion of IL-6 in HBST supernatant exposed to HD produced conflicting results. Although an increase of IL-6 was observed in control superfusion media from HBST, IL-6 levels were observed to decrease as the concentration of HD increased. Time course of IL-6 mRNA levels were performed using a competitive polymerase chain reaction (PCR) and human IL-6 mRNA assay detection kit in control and HD (100 μM)-treated HEKs cells. IL-6 mRNA transcripts in HD-exposed HEKs were first observed within 2 hours, dropped at 5 to 6 hours, and increased by ® 2.2-fold and 8.5-fold at 24 to 48 hours after HD exposure, respectively, as detected by the Xplore mRNA Quantification System. Surface-enhanced laser desorption ionization (SELDI) mass spectrometry was also applied to study the secretion pattern of IL-6 on lysate preparations of HBST. A peak in the area of 23,194 to 23,226 Da was detected using antibody coupled to the chip. This peak was assigned to correspond to the mass of the IL-6 glycoprotein. Recombinant human IL-6 (rhIL-6) exposed to HD lacked the second disulfide bridge and was partially unfolded, as determined by nuclear magnetic resonance-nuclear Overhauser enhancement and exchange spectroscopy (NMR-NOESY). The disappearance of the resonance peak at 3.54 ppm and the appearance of a new chemical shift at 1.85 ppm suggested that a change in structure had occurred in the presence of HD. From the data, the possibility cannot be excluded that IL-6 might be involved in the early event of structural changes of the signal transducer glycoprotein that indirectly initiates the cascade of events such as skin irritation and blister formation observed in the pathophysiology of HD injury.
Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol.54:1–78.
2.
Arroyo, C. M., and A. J. Carmichael. 1997. Role of cytokine and nitric oxide in the inflammatory response produced by sulfur mustard (HD). J. Chem. Soc. Perkin Trans.2:2495–2499.
3.
Arroyo, C. M., R. J. Schafer, E. M. Kurt, C. A. Broomfield, and A. J. Carmichael. 1999. Response of normal human keratinocytes to sulfur mustard (HD): Cytokine release using a non-enzymatic detachment procedure. Hum. Exp. Toxicol.18:1–11.
4.
Arroyo, C. M., R. J. Schafer, E. M. Kurt, C. A. Broomfield, and A. J. Carmichael. 2000. Response of normal human keratinocytes to sulfur mustard: Cytokine release. J. Appl. Toxicol.20:S63–S72.
5.
Arroyo, C. M., R. L. Von Tersch, and C. A. Broomfield. 1995. Activation of alpha-human tumour necrosis factor (TNF-alpha) by human monocytes (THP-1) exposed to 2-chloroethyl-ethyl sulphide (H-MG). Hum. Exp. Toxicol.14:547–553.
6.
Beavis, R. C., and B. T. Chait. 1996. Matrix-assisted laser desorption ionization mass-spectrometry of proteins. Methods Enzymol.270:519–551.
7.
Berardesca, E., and F. Distant. 1994. The modulation of skin irritation. Contact Dermatitis31:281–287.
8.
Boyce, S. T., and R. G. Ham. 1985. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J. Tissue Culture Methods9:83–93.
9.
Byrne, M. P., C. A. Broomfield, and W. E. Stites. 1996. Mustard gas crosslinking of protein through preferential alkylation of cysteines. J. Protein Chem.15:131–136.
10.
Castell, J., J. Klapproth, V. Gross, E. Walter, T. Andus, L. Snyers, J. Content, and P. C. Heinrich. 1990. Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. Eur. J. Biochem.189:113–118.
11.
Cichy, J., S. Rose-John, J. Pryjma, and J. Travis. 1996. Effect of soluble interleukin-6 receptor on interleukin-6 synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun.227:318–321.
12.
Clogston, C. L., T. C. Boone, B. C. Crandall, E. A. Mendiaz, and H. S. Lu. 1989. Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor. Arch. Biochem. Biophys.272:144–151.
13.
Corsini, E., and C. L. Galli. 1998. Cytokines and irritant contact dermatitis. Toxicol. Lett.102-103:277–282.
14.
Cowan, F. M., and C. A. Broomfield. 1993. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol. Toxicol.9:201–213.
15.
Detheux, M., H. Jijakli, and D. Lison. 1997. Effect of sulphur mustard on the expression of urokinase in cultured 3T3 fibroblasts. Arch. Toxicol.71:243–249.
16.
Gibbs, P. E., and I. M. Freedberg. 1980. Mammalian epidermal messenger RNA: Identification and characterization of the keratin messengers. J. Invest. Dermatol.74:382–388.
17.
Gross, C. L., K. C. Giles, and W. J. Smith. 1997. L-Oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol. Toxicol.13:167–173.
18.
Grossman, R. M., J. Krueger, D. Yourish, A. Granelli-Piperno, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal, and A. B. Gottlieb. 1989. Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA86:6367–6371.
19.
Guzman, J. J., S. A. Kelly, C. L. Gross, and W. J. Smith. 2000. In vitro cytotoxicity assay of human epidermal keratinocytes in culture exposed to sulfur mustard. USAMRICD Technical Report ICD TR 00 03:1–12.
20.
Hebert, C. A., F. W. Luscinskas, J. M. Kiely, E. A. Luis, W. C. Darbonne, G. L. Bennett, C. C. Liu, M. S. Obin, M. A. Gimbrone, Jr., and J. B. Baker. 1990. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J. Immunol.145:3033–3040.
21.
Heinrich, P. C., J. V. Castell, and T. Andus. 1990. Interleukin-6 and the acute phase response [review article]. Biochem. J.265:621–636.
22.
Hinshelwood, J. D., I. R. Spencer, Y. J. K. Edwards, and S. J. Perkins. 1999. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption—ionisation affinity mass spectrometry and homology modeling: Implications for the activity of factor B. J. Mol. Biol.294:587–599.
23.
Klein, B., J. Wijdenes, X. G. Zhang, M. Jourdan, J. M. Boiron, J. Brochier, J. Liautard, M. Merlin, C. Clement, B. Morel-Fournier, Z.Y Lu, P. Mannoni, J. Sany, and R. Bataille. 1991. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood78:1198–1204.
24.
Kupper, T. S., K. Min, P. Sehgal, H. Mizutani, N. Birchall, A. Ray, and L. May. 1989. Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity. Ann. N.Y. Acad. Sci.55:454–465.
25.
Lardot, C., V. Dubois, and D. Lison. 1999. Sulfur mustard upregulates the expression of interleukin-8 in cultured human keratinocytes. Toxicol. Lett.110:29–33.
26.
Lopez-Robles, E., E. Avalos-Diaz, E. Vega-Memije, T. Hojyo-Tomoka, R. Villalobos, S. Fraire, L. Domiguez-Soto, and R. Herrera-Esparza. 2001. TNF-alpha and IL-6 are mediators in the blistering process of pemphigus. Int. J. Dermatol.40:185–188.
27.
McKenzie, R. C., and D. N. Sauder. 1990. The role of keratinocytes cytokines in inflammation and immunity. J. Invest. Dermatol.95:1055–1075.
28.
Nijsten, M. W., E. R. de Groot, H. J. Ten Duis, H. J. Klasen, C. E. Hack, and L. A. Aarden. 1987. Serum levels of interleukin-6 and acute phase responses. Lancet2:921.
29.
Nishimura, C., K. Futatsugi, K. Yasukawa, T. Kishimoto, and Y. Arata. 1991. Site-specific mutagenesis of human interleukin-6 and its biological activity. FEBS Lett.281:167–169.
30.
Papirmeister, B., A. J. Feister, S. I. Robinson, and R. D. Ford. 1991. Medical defense against mustard gas. Toxic mechanisms and pharmacological implications.Boca Raton, FL: CRC Press.
31.
Price, E. O., J. R. Smith, C. R. Clark, J. J. Schlager, and M. L. Shih. 2000. MALDI-ToF/MS as a diagnostic tool for the confirmation of sulfur mustard exposure. J. Appl. Toxicol.20:S193–S197.
32.
Ray, R., R. H. Legere, B. J. Majerus, and J. P. Petrali. 1995. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol. Appl. Pharmacol.131:44–52.
33.
Rhodes, L. S., I. A. Hahim, P. J. Mclaughlin, and P. S. Friedmann. 1999. Blister fluid cytokine in cutaneous inflammatory bullous disorders. Acta Derm. Venereol.79:288–290.
34.
Rock, F. L., X. Li, P. Chong, N. Ida, and M. Klein. 1994. Roles of disulfides bonds in recombinant human interleukin-6 conformation. Biochemistry33:5146–5154.
35.
Sabourin, C. L. K., J. P. Petrali, and R. P. Casillas. 2000. Alteration in inflammatory cytokine gene expression in sulfur mustard exposed mouse skin. J. Biochem. Mol. Toxicol.14:291–302.
36.
Sapan, C. V., R. L. Lundblad, and N. C. Price. 1999. Colorimetric protein assay techniques. Biotechnol. Appl. Biochem.29:99–108.
37.
Sato, M., D. Sawamura, S. Ina, T. Yaguchi, K. Hanada, and I. Hashimoto. 1999. In vivo introduction of the interleukin 6 gene into human keratinocytes: Induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form. Arch. Dermatol. Res.291:400–404.
38.
Sawamura, D., X. Meng, S. Ina, M. Sato, K. Tamai, K. Hanada, and I. Hashimoto. 1998. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. J. Immunol.161:5633–5639.
39.
Sidell, F. R., J. S. Urbanetti, W. J. Smith, and C. G. Hurst. 1997. Vesicants. In Medical aspects of chemical and biological warfare. Part I: Warfare, weaponry, and the casualty, ed. F. R. Sidell, E. T. Takafuji, and D. R. Franz, 197–228, Washington DC: Office of The Surgeon General TMM Publications.
40.
Snouwaert, J. N., F. W. Leebeek, and D. M. Fowlkes. 1991. Role of disulfide bonds in biologic activity of human interleukin-6. J. Biol. Chem.266:23097–23102.
41.
Spencer, D. I. R., L. Robson, J. Bhatia, S. K. Sharma, N. P. Michael, N. R. Whitelegg, A. R. Rees, K. A. Chester, and R. H. J. Begent. 1999. Identifying immunogenic sites on ADEPT enzyme CPG2 using a scFv library and SELDI-AMS. Br. J. Cancer80:52.
42.
Sporri, B., K. M. Muller, U. Wiesmann, and M. Bickel. 1999. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int. Immunol.11:1053–1058.
43.
Taga, T., and T. Kuhimoto. 1990. IL-6 Receptor. In Cellular and molecular mechanisms of inflammation, ed. C. C. Cochrane and M. A. Gimbrone, Jr., 29–243. New York: Academic Press.
44.
Tanaka, F., A. M. Dannenberg, Jr., K. Higuchi, M. Nakamura, P. J. Pula, T. E. Hugli, R. G. Discipio, and D.L. Kreutzer. 1997. Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation21:251–267.
45.
Tsuruta, J., K. Sugisaki, A. M. Dannenberg, Jr., T. Yoshimura, Y. Abe, and P. Mounts. 1996. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation20:293–318.
46.
Van Damme, J., and G. Opdenakker. 1990. Interaction of interferons with skin reactive cytokines: From interleukin-1 to interleukin-8. J. Invest. Dermatol.95:90S–93S.
47.
VanSnick, J.1990. Interleukin-6: An overview. Ann. Rev. Immunol.8:253–278.
48.
Vogt, R. F., Jr, A. M. Dannenberg, Jr., B. H. Schofield, N. A. Hynes, and B. Papirmeister. 1984. Pathogenesis of skin lesions caused by sulfur mustard. Fundam. Appl. Toxicol.4:S71–S83.
49.
Willems, J.L. 1989. Clinical management of mustard gas casualties. Ann. Med. Mil. Bel.3:1–61.
50.
Woessner, J. F., Jr., A. M. Dannenberg, Jr., P. J. Pula, M. G. Selzer, C. L. Ruppert, K. Higuchi, A. Kajiki, M. Nakamura, N. M. Dahms, J. S. Kerr et al. 1990. Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard. J. Invest. Dermatol.95:717–726.
